Kostka KH - Search Results

1

Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine.

Ourique AF, Melero A, de Bona da Silva C, Schaefer UF, Pohlmann AR, Guterres SS, Lehr CM, Kostka KH, Beck RC. Ourique AF, et al. Among authors: kostka kh. Eur J Pharm Biopharm. 2011 Sep;79(1):95-101. doi: 10.1016/j.ejpb.2011.03.008. Epub 2011 Mar 22. Eur J Pharm Biopharm. 2011. PMID: 21402157

2

pH profiles in human skin: influence of two in vitro test systems for drug delivery testing.

Wagner H, Kostka KH, Lehr CM, Schaefer UF. Wagner H, et al. Among authors: kostka kh. Eur J Pharm Biopharm. 2003 Jan;55(1):57-65. doi: 10.1016/s0939-6411(02)00125-x. Eur J Pharm Biopharm. 2003. PMID: 12551704

3

Effects of various vehicles on the penetration of flufenamic acid into human skin.

Wagner H, Kostka KH, Adelhardt W, Schaefer UF. Wagner H, et al. Among authors: kostka kh. Eur J Pharm Biopharm. 2004 Jul;58(1):121-9. doi: 10.1016/j.ejpb.2004.03.014. Eur J Pharm Biopharm. 2004. PMID: 15207545

4

In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations.

Reichling J, Landvatter U, Wagner H, Kostka KH, Schaefer UF. Reichling J, et al. Among authors: kostka kh. Eur J Pharm Biopharm. 2006 Oct;64(2):222-8. doi: 10.1016/j.ejpb.2006.05.006. Epub 2006 May 23. Eur J Pharm Biopharm. 2006. PMID: 16846726

5

A strategy for in-silico prediction of skin absorption in man.

Selzer D, Neumann D, Neumann H, Kostka KH, Lehr CM, Schaefer UF. Selzer D, et al. Among authors: kostka kh. Eur J Pharm Biopharm. 2015 Sep;95(Pt A):68-76. doi: 10.1016/j.ejpb.2015.05.002. Epub 2015 May 29. Eur J Pharm Biopharm. 2015. PMID: 26022643

6

TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static Franz type diffusion cells in vitro. Limitations shown by transport data testing.

Netzlaff F, Kostka KH, Lehr CM, Schaefer UF. Netzlaff F, et al. Among authors: kostka kh. Eur J Pharm Biopharm. 2006 May;63(1):44-50. doi: 10.1016/j.ejpb.2005.10.009. Epub 2005 Dec 27. Eur J Pharm Biopharm. 2006. PMID: 16380242

7

In-silico model of skin penetration based on experimentally determined input parameters. Part I: experimental determination of partition and diffusion coefficients.

Hansen S, Henning A, Naegel A, Heisig M, Wittum G, Neumann D, Kostka KH, Zbytovska J, Lehr CM, Schaefer UF. Hansen S, et al. Among authors: kostka kh. Eur J Pharm Biopharm. 2008 Feb;68(2):352-67. doi: 10.1016/j.ejpb.2007.05.012. Epub 2007 May 29. Eur J Pharm Biopharm. 2008. PMID: 17587558

8

Influence of the application area on finite dose permeation in relation to drug type applied.

Hahn T, Selzer D, Neumann D, Kostka KH, Lehr CM, Schaefer UF. Hahn T, et al. Among authors: kostka kh. Exp Dermatol. 2012 Mar;21(3):233-5. doi: 10.1111/j.1600-0625.2011.01424.x. Exp Dermatol. 2012. PMID: 22379974

9

Human skin penetration of flufenamic acid: in vivo/in vitro correlation (deeper skin layers) for skin samples from the same subject.

Wagner H, Kostka KH, Lehr CM, Schaefer UF. Wagner H, et al. Among authors: kostka kh. J Invest Dermatol. 2002 Mar;118(3):540-4. doi: 10.1046/j.0022-202x.2001.01688.x. J Invest Dermatol. 2002. PMID: 11874496 Free article.

10

Correlation between stratum corneum/water-partition coefficient and amounts of flufenamic acid penetrated into the stratum corneum.

Wagner H, Kostka KH, Lehr CM, Schaefer UF. Wagner H, et al. Among authors: kostka kh. J Pharm Sci. 2002 Aug;91(8):1915-21. doi: 10.1002/jps.10183. J Pharm Sci. 2002. PMID: 12115818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters